# Using Cardiovascular Magnetic Resonance Tissue Characterisation and Wearable Technology to PREDICT Clinical Outcomes, Response to Therapy and Arrhythmias in Hospitalised Heart Failure Patients

> **NCT03689426** · — · UNKNOWN · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 150 (estimated)

## Conditions studied

- Heart Failure
- Diffuse Fibrosis
- Focal Fibrosis
- Arrythmia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03689426
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-30
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03689426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03689426, "Using Cardiovascular Magnetic Resonance Tissue Characterisation and Wearable Technology to PREDICT Clinical Outcomes, Response to Therapy and Arrhythmias in Hospitalised Heart Failure Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03689426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*